Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX

Information

  • Research Project
  • 7679714
  • ApplicationId
    7679714
  • Core Project Number
    U01DD000204
  • Full Project Number
    5U01DD000204-04
  • Serial Number
    204
  • FOA Number
    RFA-DD-06-005
  • Sub Project Id
  • Project Start Date
    9/30/2006 - 19 years ago
  • Project End Date
    9/29/2011 - 14 years ago
  • Program Officer Name
    BLACKMAN, DONALD
  • Budget Start Date
    9/30/2009 - 16 years ago
  • Budget End Date
    9/29/2010 - 15 years ago
  • Fiscal Year
    2009
  • Support Year
    4
  • Suffix
  • Award Notice Date
    7/15/2009 - 16 years ago

Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX

DESCRIPTION (provided by applicant): The purpose of this application is to measurably prevent and reduce the complications of inherited bleeding disorders among residents of Region DC - California, Hawaii, Nevada and Guam. This will be accomplished by continued implementation of diagnostic, clinical management, education, outreach, standardized surveillance, and prevention services that reduce hemophilia morbidity and mortality by 40%. Services will be conducted by the Region DCs 14 multidisciplinary Hemophilia Treatment Centers (HTC), and its regional administrative office. These entities have been part of the nearly 30-year-old U.S. bleeding disorder infrastructure that is organized into 12 regions and provide services per federal CDC, HRSA and Healthy People 2010 priorities for Americans with disabilities to live longer healthier lives. Our HTCs and regional office will: (1) Expand clinical assessment, prevention, surveillance, outreach, education, consultation, and management services for people of all ages and racial/ethnic backgrounds who have hemophilia, von Willebrand Disease and other inherited bleeding and clotting disorders in our catchment area that are directed at attaining and measuring specific outcomes to reduce complications;(2) Expand the cohort through continued recruitment and standard data collection;(3) Transition the national database from paper to electronic, from email to web-based;(4) Expand the database to collect new data related to women's ssues in coagulation, rare bleeding disorders, prophylaxis, factor utilization, thrombophilia, inhibitors, and other important clinical outcomes;(5) Design and pilot additional studies aimed at further characterizing these populations through the expanded access to a) gene-based diagnosis and b) more precise definition of the biochemical phenotype;(6) Design prevention messages and strategies, clinical trials and data sharing with other relevant agencies;and (7) Maintain a regional office which will support the HTC network and assess the efficacy of prevention services.

IC Name
CENTERS FOR DISEASE CONTROL AND PREVENTION
  • Activity
    U01
  • Administering IC
    DD
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    799000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NCBDD:799000\
  • Funding Mechanism
    Research Projects
  • Study Section
    ZCD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CHILDREN'S HOSPITAL OF ORANGE COUNTY
  • Organization Department
  • Organization DUNS
    796024966
  • Organization City
    ORANGE
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    928683874
  • Organization District
    UNITED STATES